Is there an FDA-approved sermorelin product?

Not one that is marketed. Geref, a sermorelin product for children with growth failure, was cleared for sale in 1997, and both it and an earlier diagnostic version had their approvals withdrawn in 2009 after the maker discontinued them. The agency later confirmed the withdrawal was not for safety or effectiveness reasons. The compounded formulation prescribed today is not FDA-approved, and a licensed provider may still prescribe it.

What do adults take sermorelin for?

Sleep quality, body composition and recovery are the three reasons that come up most. None of them has ever been an approved use. The human studies behind them are small — ten to twenty-three people — and they show consistent effects on growth hormone with far less consistent effects on the things people actually notice, like muscle, fat and how they feel.

Is sermorelin the same as HGH?

No. Growth hormone therapy supplies the finished hormone directly. Sermorelin supplies the signal that tells your own pituitary gland to release it, so your body's normal feedback controls stay in the loop and the amount released is still your pituitary's decision. They are different medicines with different effects, not two versions of the same thing.

How long does sermorelin take to do anything?

The hormone response is fast and the rest is slow. In the published studies, growth hormone rose within the first night or two of dosing, and IGF-1 shifted within about two weeks where it shifted at all. Changes people can perceive, such as sleep quality, were reported over weeks rather than days — and in several studies did not appear at all.

Is sermorelin a steroid?

No. Anabolic steroids are synthetic versions of testosterone and act on androgen receptors. Sermorelin is a 29-amino-acid peptide that copies a hypothalamic signalling hormone and acts on the pituitary. The two work through unrelated pathways, and sermorelin is prescribed and dispensed as a compounded medication rather than as a controlled substance.

What Is Sermorelin Used For? A Plain Answer

What is sermorelin used for? Officially, one thing, and it was a long time ago: helping children who weren't growing properly. That approval ended in 2009. Today adults are prescribed compounded sermorelin for sleep, body composition and recovery — reasons no regulator has ever signed off on, resting on a handful of small studies from the 1990s.

That's the honest version, and it's worth having before you read anything else about it.

Sermorelin is a 29-amino-acid copy of the front end of growth-hormone-releasing hormone — the signal your hypothalamus already sends to your pituitary gland at night, telling it to release growth hormone. Sermorelin does not add hormone from outside. It presses the same doorbell your body already uses.

The one thing sermorelin was approved for

A product called Geref. It was approved on September 26, 1997 for idiopathic growth hormone deficiency in children with growth failure — children whose bodies weren't making enough growth hormone to grow normally. A second version, on the market since December 28, 1990, was a diagnostic: a clinician injected a tiny amount to see whether someone's pituitary could release growth hormone at all.

Then the maker stopped selling both. EMD Serono wrote to the FDA in 2008 saying it was discontinuing them, and both approvals were formally withdrawn in a notice published on May 19, 2009. Four years later, prompted by a citizen petition, the agency looked again and determined that Geref had not been withdrawn for reasons of safety or effectiveness. A commercial decision, in other words. Not a recall.

So there is no FDA-approved sermorelin product on the U.S. market today, and the compounded version a licensed pharmacy prepares for one patient is not FDA-approved either. Compounded medicines are not reviewed by the FDA for safety, effectiveness or quality. That is a fact about paperwork rather than a verdict on the molecule — a licensed provider may still prescribe a compounded formulation, and that decision sits between you and your doctor.

What is sermorelin used for in adults today

Three reasons come up again and again. Here is what sits behind each one, including the parts the marketing tends to leave out.

Sleep. Growth hormone is released mostly in the first deep stretch of the night, so the idea that a GHRH signal and sleep are connected is not a stretch. The clearest human result is a 1999 study in Lübeck, Germany: twelve younger men and eleven older men each got 300 micrograms of GHRH one night and a placebo another, half an hour before bed, wired up to a sleep monitor. On the GHRH nights they had more deep sleep and more REM sleep, concentrated in the second half of the night. Two things to hold onto: that GHRH went up the nose rather than into the skin, and twenty-three men is a small study.

Body composition. The reasoning here is a chain. Raise growth hormone; raise IGF-1, the hormone that does most of growth hormone's downstream work; and body composition follows. The first two links have genuinely been shown. In a 1992 study at the National Institute on Aging, ten healthy men around 68 injected GHRH twice a day for two weeks, and at the higher of two doses their growth hormone and IGF-1 came up to levels no longer statistically different from men in their twenties. That is a hormone result. Whether the third link holds is a separate question, and a harder one.

Recovery and strength. In 1997, eleven men aged 64 to 76 injected GHRH nightly for six weeks. Their overnight growth hormone rose. Their IGF-1 did not move at all. Two of six strength tests — upright row and shoulder press — improved, along with an endurance test, but a DEXA scan found no change in muscle or fat, and no change in weight, blood sugar or blood lipids. The researchers' own reading was that one injection a night is probably weaker than spreading doses through the day. No significant side effects turned up.

That is the shape of the evidence: real hormone effects, patchy downstream effects, and studies with ten or eleven people in them. What the sermorelin trials actually found goes through those numbers in more detail than there is room for here.

Why a prescription sometimes pairs it with a second peptide

Sermorelin clears the bloodstream in minutes, so one injection produces one short pulse. That's the reason some prescriptions pair a GHRH-type peptide with a growth hormone secretagogue — a compound that works on the ghrelin receptor instead, a different door into the same pituitary cell. The two signals are complementary rather than duplicative, which is the whole rationale for combining them.

What sermorelin is not

It is not HGH. Growth hormone therapy injects the finished hormone. Sermorelin injects the upstream signal and leaves your pituitary to decide how much to release, which is why the two behave differently in the body — sermorelin versus HGH covers that comparison properly.

It is not a steroid. Anabolic steroids are synthetic testosterone and work on an entirely different receptor. Peptides like sermorelin are short chains of amino acids that copy a signalling molecule; the difference between peptides and steroids is not a matter of degree.

It is not a weight-loss drug. The older-adult studies above measured body fat and didn't find reliable change in it.

A June 2026 review, and the gap it describes

As of September 6, 2026, the day this article was written, the most recent broad look at these compounds is a review published on June 18, 2026 in Frontiers in Endocrinology, which sorts growth-hormone-axis peptides into tiers by how much human evidence each one actually has — from randomised-trial data at the top down to compounds with no human studies at all. It puts sermorelin alongside tesamorelin, CJC-1295 and ipamorelin, and it catalogues what clinicians see in people who bought these online: hormone and metabolic disturbances, fluid retention, joint and muscle aches, injection-site reactions.

It is worth being precise about what that review is and is not. It is a summary of existing work, not new trial data, and it does not say sermorelin fails to do anything. What it says is that the confident protocols circulating online run well ahead of what has been measured in people — which is an argument for a clinician being involved, not an argument against the compound.

How a sermorelin prescription actually happens

The path is shorter than most people expect. You complete an intake questionnaire specific to sermorelin — medical history, current medications, what you are hoping to address. A licensed provider reads it against your history and decides. If they prescribe, a licensed U.S. compounding pharmacy prepares it for you and ships it cold; if they do not, they say so and explain why. A licensed provider reviews every request and prescribes only when it is appropriate, and not everyone qualifies.

Dose and schedule come from that provider and the dispensing pharmacy, not from a protocol you find online — the studies above used doses from 0.5 mg to 2 mg in research settings, which tells you what was measured, not what anyone should do. How peptides get prescribed walks through the whole sequence if you want it step by step.